Arcutis Biotherapeutics, Inc. Quarterly Return On Assets in % from Q3 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Arcutis Biotherapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2020 to Q3 2024.
  • Arcutis Biotherapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -46 %, a 38.1% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Return On Assets for 2023 was -78.6 %, a 2.35% decline from 2022.
  • Arcutis Biotherapeutics, Inc. annual Return On Assets for 2022 was -76.8 %, a 58.1% decline from 2021.
  • Arcutis Biotherapeutics, Inc. annual Return On Assets for 2021 was -48.6 %, a 12.1% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -46 +28.3 +38.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -51 +28.8 +36% Apr 1, 2024 Jun 30, 2024
Q1 2024 -60.7 +19.2 +24.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -78.6 -1.8 -2.35% Oct 1, 2023 Dec 31, 2023
Q3 2023 -74.3 +4.31 +5.48% Jul 1, 2023 Sep 30, 2023
Q2 2023 -79.8 -8.54 -12% Apr 1, 2023 Jun 30, 2023
Q1 2023 -79.9 -21 -35.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -76.8 -28.2 -58.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -78.6 -36.1 -84.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -71.3 -28.3 -66% Apr 1, 2022 Jun 30, 2022
Q1 2022 -59 -11 -23% Jan 1, 2022 Mar 31, 2022
Q4 2021 -48.6 +6.66 +12.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -42.6 +15.2 +26.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -42.9 Apr 1, 2021 Jun 30, 2021
Q1 2021 -47.9 Jan 1, 2021 Mar 31, 2021
Q4 2020 -55.2 Oct 1, 2020 Dec 31, 2020
Q3 2020 -57.7 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.